Tg Therapeutics (TGTX) Share-based Compensation (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Share-based Compensation of $21.2 million for Q1 2026, up 32.77% year-over-year from $16.0 million in Q1 2025, and up 35.45% quarter-over-quarter from $15.7 million in Q4 2025.
Tg Therapeutics (TGTX) Share-based Compensation (2011 - 2026) Analysis & Trends
Tg Therapeutics' Share-based Compensation history runs 16 years deep, the most recent figure standing at $21.2 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 32.77% year-over-year to $21.2 million; the TTM figure through Mar 2026 stood at $21.2 million (down 61.32% YoY), while the FY2025 annual figure was $64.7 million, up 39.6% from the prior year.
- Share-based Compensation for Q1 2026 stood at $21.2 million, up from $15.7 million in the prior quarter.
- The five-year high for Share-based Compensation was $42.5 million in Q3 2025, with the low at -$975000.0 in Q2 2022.
- The 5-year median for Share-based Compensation is $12.7 million (2024), against an average of $14.7 million.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation plunged 105.98% in 2022, then soared 1493.03% in 2023.
- Tg Therapeutics' Share-based Compensation stood at $36.6 million in 2022, then sank by 66.44% to $12.3 million in 2023, then increased by 28.22% to $15.7 million in 2024, then declined by 0.51% to $15.7 million in 2025, then jumped by 35.45% to $21.2 million in 2026.
- Business Quant data shows TGTX's Share-based Compensation at $21.2 million in Q1 2026, $15.7 million in Q4 2025, and $42.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 13.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.09 Mn |
| Jun 30, 2026 | 13.09 Mn |
| Mar 31, 2026 | 21.20 Mn |
| Mar 31, 2026 | 21.20 Mn |
| Dec 31, 2025 | 15.65 Mn |
| Dec 31, 2025 | 15.65 Mn |
| Sep 30, 2025 | 42.50 Mn |
| Sep 30, 2025 | 42.50 Mn |
| Jun 30, 2025 | 17.40 Mn |
| Jun 30, 2025 | 17.40 Mn |
| Mar 31, 2025 | 15.97 Mn |
| Mar 31, 2025 | 15.97 Mn |
| Dec 31, 2024 | 15.73 Mn |
| Dec 31, 2024 | 15.73 Mn |
| Sep 30, 2024 | 12.66 Mn |
| Sep 30, 2024 | 12.66 Mn |
| Jun 30, 2024 | 10.45 Mn |
| Jun 30, 2024 | 10.45 Mn |
| Mar 31, 2024 | 10.30 Mn |
| Mar 31, 2024 | 10.30 Mn |